调查最佳的特拉费林剂量和注射前因素在声麻声麻
Tomohiro Hasegawa1,2, Yusuke Watanabe1,3
1Tokyo Voice Center, International University of Health and Welfare, Tokyo, Japan.
The Laryngoscope
|October 23, 2025
概括
较高的特拉费明剂量改善了单边声麻 (UVFP) 的语音结果. 注射前的因素也预测了内脉内特拉费林注射 (ITI) 后的声音改善.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 再生医学是一种再生医学.
- 语音科学 语言科学
背景情况:
- 单侧声麻 (UVFP) 显著影响声音质量和生活质量.
- 最佳的治疗策略,包括特拉费明剂量和内脉内特拉费明注射 (ITI) 的预测因素,需要进一步澄清.
研究的目的:
- 为了确定UVFP患者对ITI的最佳特拉费林剂量.
- 确定注射前的因素,预测ITI后的语音改善.
主要方法:
- 对198名接受ITI的UVFP患者进行了回顾性分析.
- 语音参数的评估,包括最大发音时间 (MPT),音调范围 (PR),平均流速 (MFR) 和语音障碍指数 (VHI).
- 患者被分为低 (<100微克),正常 (100微克) 和高 (>100微克) 的特拉弗林剂量组.
主要成果:
- 在剂量组中观察到MPT,MFR和VHI的显著改善.
- 高剂量组与正常剂量组相比,显示出明显更好的结果.
- 注射前的值和并发症被确定为声音改善的显著预测因素.
结论:
- 较高的特拉费明剂量可能会导致UVFP患者的声音更大,更持续地改善.
- 建议采用个性化治疗方法,通过根据注射前的因素确定最佳候选人.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...


